s6y
Company name or ticker
Search
Aligos Therapeutics, Inc.
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filed
Wednesday, August 26, 2020
Accession number
0000950123-20-009341
Documents
filename1.htm
DRS
On sec.gov
Filing index
All files
Complete submission text
SGML header